<DOC>
	<DOCNO>NCT01396993</DOCNO>
	<brief_summary>Breast conserve therapy ( BCT ) standard treatment intraductal invasive breast cancer patient . However cosmetic result , e.g . symmetry nipple displacement , sometimes poor reduce quality life . The use immediate technique oncoplastic surgery ( iTOP ) seem improve subjective cosmetic outcome . Oncologic safety iTOP demonstrate several author use restrospective analysis . However , prospective observational trial do objectively evaluate cosmetic oncologic outcome compare BCT iTOP . The aim study investigate issue within prospective non randomize observational trial Medical University Vienna .</brief_summary>
	<brief_title>Prospective Non-randomized Evaluation Oncoplastic Surgery</brief_title>
	<detailed_description />
	<criteria>Patients schedule unilateral breast conserving surgery due cancer suspicious lesion , &gt; 10 % * breast volume ( measured mammogram use define formular 37 ) remove breast cancer patient schedule mastectomy immediate reconstruction ( immediate delay contralateral correction allow ) BIRADS IV , V VI eligible &gt; 18 year age Psychological physical capable understand perform trial Signed write informed consent * If oncologic safety necessitates resect half one breast quadrant Inflammatory breast cancer Progression neoadjuvant therapy Pregnant woman Patients unable perform surgery general anaesthesia Bilateral breast lesion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>